Polydatin
虎杖苷
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NamePolydatin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Neptunus Pharmaceutical Co Ltd
Inactive CompaniesNeptunus Pharmaceuticals Inc
Active Indications
Inactive Indications +[4]